Bionova Capital

Type

Venture Capital

Status

Active

Location

Lisbon, Portugal

Total investments

8

Average round size

3M

Portfolio companies

5

Rounds per year

1.14

Follow on index

0.38

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyInformation ServicesArtificial IntelligenceMachine LearningHealth CareHospitalMedical DeviceMedical

Investor highlights

Industry focus
Biotech/Life SciencesMedtechHealthcare
Stage focus
Seed
Geo focus
AlbaniaAustriaBelgiumBosnia and HerzegovinaBulgaria Show 37 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
EUR 51000000
Fund raised date
2024-07-10

Analytics

Total investments
8
Lead investments
0
Rounds per year
1.14
Follow on index
0.38
Investments by industry
  • Medical Device (4)
  • Health Care (4)
  • Biotechnology (3)
  • Hospital (2)
  • Medical (2)
  • Show 5 more
Investments by region
  • United Kingdom (4)
  • Portugal (4)
Peak activity year
2018

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
5
Avg. valuation at time of investment
472K
Group Appearance index
0.88

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Delox 18 May 2022 Health Care, Hospital Seed 885K Lisbon, Portugal, Portugal

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.